MedBen Rx Blog
Combatting Drug Price Increases Requires Proven Saving Solutions
From a new report published by the U.S. Department of Health & Human Services: "Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46 percent were larger than the rate of inflation. The average drug price...
The PBM “Non-Rebate” Rebate Shuffle
In their continuing quest for bigger profits, major pharmacy benefit managers (PBMs) have adapted a new tactic: clever wordplay. What was once known as a "rebate" – a partial refund of the drug payment back to the plan – now goes by a variety of other terms, such as...
MedBen Rx Humira Biosimilar Recommendation
Here’s some cost-saving news for MedBen Rx clients who use Ventegra as their processor. On July 1, 2023, biosimilar products were released for the popular and expensive anti-inflammatory therapy, Humira. A 30-day supply of Humira, which is used to treat a variety of...
Diagnosis Code Required for Certain Ozempic Prescriptions
Important information for MedBen Rx clients using the Ventegra formulary: Effective October 1, an appropriate ICD-10 diagnosis code for type 2 diabetes will be required for certain Ozempic prescriptions and all other GLP-1 class medications. Ozempic and other GLP-1...
Fraker Discusses Drug Reimportation at Healthcare Innovation Conference
MedBen Senior Vice President Caroline Fraker was a featured speaker at the 10th Annual Sherrill-Morgan Healthcare Innovation Conference on September 15th. She spoke on the topic of drug importation, including the reimportation of U.S. manufactured prescription drugs...
MedBen Solutions Battle Cost Increases
A new survey by International Foundation of Employee Benefit Plans found employers expect plan costs to increase seven percent in 2024. As to why, they gave a range of answers, with the top four reasons representing 71 percent of responses (see chart below). As it...
Fighting Pharmacy Fraud, One Claim at a Time
The Texas Attorney General’s Office recently announced the recovery of $42.7 million in taxpayer funds… the result of enforcement action against six pharmaceutical drug manufacturers alleged to have committed fraud. The companies’ violations included providing...
MedBen Rx Client Saves 39% by Tackling Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Transparency, Value Commitment Counter PBM Concerns
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
Download the 2023 MedBen Client Report Now!
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan....
MedBen Turns 85
May 8, 2023 marks MedBen’s 85th anniversary of serving the health benefit needs of employers across the country. As such, it’s an opportune time to reflect, while also looking forward. MedBen’s growth over the decades has coincided with the evolution in group health...
Getting Down to the (MedBen) Basics
Health benefits management can be a complicated business, but that doesn’t mean it has to be. To help make things a bit more clear cut, MedBen offers dozens of MedBen Basic handouts on a variety of topics. While many of our Basics are directed at plan...